 |
Arcus Biosciences
Last updated: January 20, 2024
Founders: Terry Rosen, Juan Jaen
Country: USA | Funding: $647.1M (+)
Website: https://www.arcusbio.com/
Arcus discovers and develops innovative cancer immunotherapies based on known but under-exploited biology. Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Website: https://www.arcusbio.com/
Arcus discovers and develops innovative cancer immunotherapies based on known but under-exploited biology. Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
